At Boston University, a team of researchers is working to better understand how language and speech is processed in the brain, and how to best rehabilitate […]
Results from the Phase II cohort of the CodeBreaK 100 study showed that treatment with the KRAS G12C inhibitor sotorasib achieved a 37.1% objective response rate […]
When health worker Neelam Kumari knocks on doors in Indian villages the occupants sometimes run out the back, terrified that she wants to vaccinate them against […]